Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 12, Issue 6, Pages 683-689Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2012.09.007
Keywords
-
Categories
Funding
- Ludwig Institute for Cancer Research
- Institut National de la Sante et de la Recherche Medicale
- University of Toulouse III
- Institut Claudius Regaud
- Fondation de France
- Institut National du Cancer
- Conseil Regional de Midi-Pyrenees
Ask authors/readers for more resources
The oncoprotein MUC-1 was shown to upregulate the transcription of genes encoding cholesterol and lipid metabolic enzymes and correlated with a resistance to Tamoxifen (Tam) despite the presence of estrogen receptor a in breast cancer tumors. The importance of this observation is supported by molecular studies on Tam suggesting two additional pharmacological targets involved in cholesterol metabolism. These observations demonstrate the potential importance of cholesterol and lipid metabolism in the pharmacology/therapeutic effects of Tam.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available